Dual action of epigallocatechin-3-gallate in virus-induced cell Injury

CONCLUSIONS: The EGCG has proven to be an efficient antiviral against SARS-CoV-2 and HSV-2, as well as a wound-healing phytochemical. We assume that EGCG may be a promising option for slowing the course of acute cellular damage induced by systemic (Coronavirus Disease 2019 (COVID-19)) or topical (HSV-2) viral infections.PMID:38012348 | DOI:10.1186/s43141-023-00624-4

Source: Herpes - November 27, 2023 Category: Infectious Diseases Authors: Ahmed Mostafa Gomaa Mostafa-Hedeab Hany Abdelfattah Elhady Esraa Ahmed Mohamed Abozer Y Eledrdery Sager Holyl Alruwaili Ahmed Mohamed Al-Abd Abdou Kamal Allayeh Source Type: research